Sign in

You're signed outSign in or to get full access.

WILLIS TOWERS WATSON (WTW)

--

Earnings summaries and quarterly performance for WILLIS TOWERS WATSON.

Research analysts who have asked questions during WILLIS TOWERS WATSON earnings calls.

Recent press releases and 8-K filings for WTW.

Willis Towers Watson issues senior notes to fund Newfront acquisition
WTW
Debt Issuance
M&A
  • Willis North America Inc. issued $700 million of 4.550% Senior Notes due March 15, 2031 and $300 million of 5.150% Senior Notes due March 15, 2036, fully guaranteed by WTW and certain subsidiaries.
  • Interest on the notes accrues from December 22, 2025 and is payable semiannually on March 15 and September 15, beginning September 15, 2026.
  • Net proceeds of approximately $990 million will fund the Newfront acquisition and related fees, repay $550 million of 4.400% notes due 2026, with any remainder for general corporate purposes.
  • The 2036 Notes include a special mandatory redemption at 101% of principal if the Newfront acquisition is not completed by the outside date, currently September 9, 2026.
3 days ago
WTW prices $1B senior unsecured notes offering
WTW
Debt Issuance
  • Willis Towers Watson’s subsidiary priced $700 million 4.550% senior unsecured notes due 2031 and $300 million 5.150% senior unsecured notes due 2036.
  • Notes are fully and unconditionally guaranteed by Willis Towers Watson and certain subsidiaries.
  • If the Newfront acquisition closes, proceeds will fund the acquisition and repay $550 million of 4.400% notes due 2026; otherwise, proceeds (with cash on hand) will repay the 2026 notes and redeem the 2036 notes, with any excess for general corporate purposes.
  • The offering—not contingent on the Newfront deal—is expected to close on December 22, 2025.
Dec 15, 2025, 11:30 PM
WTW to acquire Newfront
WTW
M&A
  • WTW will acquire Newfront for a total consideration of $1.3 billion, comprising $1.05 billion upfront (≈$900 M cash, $150 M equity) and up to $250 M contingent consideration.
  • The deal is expected to generate ≈$35 million of run-rate cost synergies by end-2028 and is valued at ~12× Newfront’s 2026E pro forma adjusted EBITDA inclusive of synergies.
  • Financing will be via new long-term debt, with the transaction estimated to be $0.10 dilutive to Adjusted EPS in 2026 and accretive in 2027; closing is anticipated in 1Q26.
  • Strategically, the acquisition expands WTW’s footprint in the U.S. middle market and high-growth sectors (technology, fintech, life sciences), while adding advanced AI and digital capabilities to its platform.
Dec 10, 2025, 2:00 PM
WTW announces acquisition of Newfront
WTW
M&A
  • WTW agreed to acquire Newfront, a top-40 U.S. insurance broker, to expand its U.S. middle-market broking business and proprietary AI-enabled tech platform, targeting closing in Q1 2026.
  • Consideration includes $1.05 billion upfront (​$900 million cash, $150 million equity) plus up to $250 million in contingent consideration and up to $150 million earn-out, totaling $1.3 billion, or ~12× 2026 pro forma Adjusted EBITDA.
  • The deal is projected to deliver $35 million of run-rate cost synergies by end-2028 (5% in 2026, 55% by 2027, 100% by 2028) against ~$125 million of transaction and integration costs over three years.
  • Combines Newfront’s AI-driven “Navigator” and placement automation with WTW’s global broking scale and analytics to create an end-to-end digital platform, enhancing sales productivity and cross-selling opportunities.
Dec 10, 2025, 2:00 PM
WTW to acquire Newfront insurance broker
WTW
M&A
  • WTW will acquire Newfront for $1.05 billion upfront (≈ $900 million cash, $150 million equity) plus up to $250 million contingent consideration and a potential $150 million earnout, with $100 million in retention equity, bringing total consideration to $1.3 billion.
  • The deal expands WTW’s U.S. middle-market and specialty broking footprint and adds Newfront’s proprietary AI-enabled Navigator platform and agentic AI placement tools to WTW’s technology stack.
  • Expected run-rate cost synergies of $35 million by end-2028 (5% realized in 2026, 55% in 2027, 100% in 2028) against $125 million of integration costs over three years; transaction is ~$0.10 dilutive to 2026 Adjusted EPS and accretive in 2027.
  • Subject to regulatory approvals, closing is anticipated in Q1 2026.
Dec 10, 2025, 2:00 PM
WTW announces acquisition of UK fintech pensions provider Cushon
WTW
M&A
  • WTW’s UK business will acquire Cushon from NatWest Group, adding £4 billion in assets under management and 730,000 members to its defined contribution master trust portfolio alongside LifeSight’s £26 billion AUM and 430,000 members.
  • The deal bolsters WTW’s position in the UK DC master trust market, which grew 35% in 2024 and is expected to average 18% annual growth over the next decade.
  • A referral arrangement ensures NatWest’s commercial banking customers continue to have seamless access to Cushon’s workplace pensions and savings services.
  • The transaction is subject to regulatory approval and is anticipated to close in the first half of 2026.
Dec 10, 2025, 12:44 PM
WTW announces acquisition of Newfront for $1.3 B
WTW
M&A
  • WTW signed a definitive agreement to acquire Newfront Insurance Holdings for total consideration of $1.3 billion, including $1.05 billion upfront and up to $250 million contingent on performance, subject to regulatory approvals.
  • The deal expands WTW’s footprint in the U.S. middle market and high-growth sectors (technology, fintech, life sciences) and integrates Newfront’s AI-driven broking platform with WTW’s digital trading capabilities.
  • Transaction is expected to close in Q1 2026, be $0.10 dilutive to adjusted EPS in 2026 and accretive in 2027.
  • WTW anticipates run-rate cost synergies of $35 million by end-2028, with transaction expenses of $25 million, cash integration costs of $100 million and one-time non-cash charges of $30 million.
Dec 10, 2025, 11:42 AM
WTW to acquire Newfront
WTW
M&A
  • WTW signed a definitive agreement to acquire Newfront, a top-40 U.S. broker combining deep specialty expertise and cutting-edge technology, expanding its U.S. middle-market and high-growth specialties presence.
  • The deal value is $1.3 billion, consisting of $1.05 billion upfront (≈$900 million cash and $150 million equity) and up to $250 million of contingent equity payments, plus an additional $150 million if above-target revenue growth is achieved.
  • Newfront has delivered 20% organic revenue CAGR from 2018–2024, driven by its proprietary technologies and agentic AI, which will integrate with WTW’s Neuron platform to enhance end-to-end digital broking capabilities.
  • The transaction is expected to close in Q1 2026, be ~$0.10 dilutive to Adjusted EPS in 2026 and accretive in 2027, and deliver $35 million of run-rate cost synergies by end-2028.
Dec 10, 2025, 11:00 AM
WTW reports energy market rate softening persists
WTW
  • The upstream energy market delivered record profitability, with market softening accelerating since April and insurers rewarding long-term relationships.
  • Downstream insurers have incurred around US$3.5 billion in losses this cycle—six of eight major losses in the US refining sector—prompting 10–15% standard rate reductions and up to 20–50% in competitive tenders for clean-loss clients.
  • Key 2026 trends include leveraging operational relationships for upstream construction placements, constrained capacity in subsea construction, and insurer top-up reinsurance purchases indicating strategic direction.
  • Insurers reported strong Q3 financial results, with capacity oversupply simplifying placement structures and yielding premium savings for Q4 2025 renewals.
Nov 13, 2025, 8:00 AM
Willis Towers Watson projects double-digit healthcare cost inflation into 2026
WTW
  • Global medical benefits costs are expected to rise by 10.3% in 2026, following 10.0% in 2025 and 9.5% in 2024.
  • Asia Pacific will see the highest increase at 14.0%, while Latin America accelerates most, from 10.5% in 2025 to 11.9% in 2026.
  • North America and Europe are forecast to moderate to 9.2% and 8.2%, respectively, in 2026.
  • New medical technologies are cited by 74% of insurers as the primary driver of ongoing cost inflation.
Nov 11, 2025, 4:21 PM

Quarterly earnings call transcripts for WILLIS TOWERS WATSON.